NRXP Balance Sheets
(Quarterly, GAAP in millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
ASSETS |
Cash & cash equivalent |
8.90 |
14.97 |
16.51 |
20.05 |
18.25 |
Cash, Cash Eqvivalents Other |
- |
- |
- |
- |
- |
Cash
& Short-term Investments |
8.90 |
14.97 |
16.51 |
20.05 |
18.25 |
Accounts receivable |
- |
- |
- |
- |
- |
Other Receivables |
- |
- |
- |
- |
- |
Notes Receivable, Current |
- |
- |
- |
- |
- |
Inventories |
- |
- |
- |
- |
- |
Other Current Assets |
0.00 |
- |
- |
0.00 |
- |
Prepaid Expense And Other Assets Current |
4.19 |
4.82 |
5.25 |
5.74 |
6.55 |
Total Current Assets |
13.09 |
19.79 |
21.76 |
25.80 |
24.80 |
Equipment/Property/Plant Net |
- |
- |
- |
- |
- |
Goodwill net |
- |
- |
- |
- |
- |
Intangible Assets |
- |
- |
- |
- |
- |
Long-term investments |
- |
- |
- |
- |
- |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Tax Assets, Noncurrent |
- |
- |
- |
- |
- |
Other Assets, Noncurrent |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
Total Assets |
13.11 |
19.81 |
21.78 |
25.82 |
24.82 |
LIABILITIES |
Accounts Payable, Current AC |
3.63 |
2.21 |
3.78 |
2.08 |
2.17 |
Accrued Liabilities, Current AC |
4.73 |
5.78 |
5.05 |
4.86 |
5.07 |
Derivative Liability, Current DE |
0.01 |
0.04 |
0.03 |
0.04 |
- |
Shortterm Debt |
- |
- |
- |
- |
- |
Other Liabilities, Current |
10.96 |
14.59 |
13.21 |
8.62 |
- |
Taxes Payable |
- |
- |
- |
- |
- |
Deferred Liability and Revenue |
- |
- |
- |
- |
- |
Business Combination, Contingent Consideration, Liability, Current BU |
- |
- |
- |
- |
- |
NotesPayableAndAccruedInterestNonCurrent |
- |
- |
- |
2.82 |
- |
Accrued Clinical Site Costs |
0.58 |
1.12 |
1.02 |
0.91 |
0.75 |
Contract With Customer Liability Current |
- |
- |
- |
- |
0.06 |
Notes Payable And Accrued Interest Current |
- |
- |
- |
- |
- |
Accrued Settlement Expense |
- |
- |
- |
- |
- |
Total Current Liabilities |
19.33 |
22.62 |
22.06 |
15.59 |
7.24 |
Long-term debt |
- |
- |
- |
- |
- |
Capital Lease and Other |
- |
- |
- |
- |
- |
Long-term Debt Convertible |
- |
- |
- |
- |
- |
Total
Long-term Debt |
- |
- |
- |
- |
- |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Deferred credits, Noncurrent |
- |
- |
- |
- |
- |
Accrued Income Taxes, Noncurrent |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Other liabilities, Noncurrent |
- |
- |
- |
2.82 |
8.04 |
Total Liabilities |
19.33 |
22.62 |
22.06 |
18.41 |
8.04 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
0.08 |
0.08 |
0.07 |
0.07 |
0.07 |
Additional Paid In Capital Common Stock |
242.53 |
239.89 |
233.58 |
230.34 |
229.47 |
Retained Earnings / Accumulated Deficit |
-248.82 |
-242.75 |
-234.04 |
-223.00 |
-212.76 |
Other Equity |
-0.02 |
-0.02 |
0.11 |
0.00 |
0.00 |
Common Stockholder's Equity |
-6.22 |
-2.81 |
-0.28 |
7.41 |
16.78 |
Preferred Stockholder's Equity |
0.00 |
- |
- |
- |
- |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
-6.22 |
-2.81 |
-0.28 |
7.41 |
16.78 |
Liabilities & Stockholder's
Equity |
13.11 |
19.81 |
21.78 |
25.82 |
24.82 |